Barcelona, Spain

Elena Carceller Gonzalez


 


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Sant Cugat del Vallé, ES (2014)
  • Barcelona, ES (2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elena Carceller Gonzalez: Innovator in Pharmaceutical Compounds

Introduction

Elena Carceller Gonzalez is a notable inventor based in Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various health conditions. Her innovative work has garnered attention, although she currently holds no patents.

Latest Patents

Elena's latest patents include two significant inventions. The first is titled "Dipeptidyl Ketoamide Compounds And Their Use For The Treatment And/or Prevention Of Fat Accumulation." This invention focuses on the use of dipeptidyl ketoamide compounds to prevent the accumulation of triglycerides in adipose tissue or to reduce the amount of triglycerides in individuals who require such treatment. The second patent is "Aminoalkylpyrimidine Derivatives As Histamine H4 Receptor Antagonists." This invention involves aminoalkylpyrimidine derivatives that serve as histamine H4 receptor antagonists, showcasing her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Elena has worked with several prominent companies in the pharmaceutical industry. Notable among these are Draconis Pharma, S.L. and Medicis Pharmaceutical Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas.

Collaborations

Elena has collaborated with various professionals in her field, including Marina Virgili Bernado and Jordi Salas Solana. These collaborations have contributed to her research and development efforts, enhancing the impact of her work.

Conclusion

Elena Carceller Gonzalez is a dedicated inventor whose work in pharmaceutical compounds demonstrates her commitment to advancing medical science. Her innovative contributions, although currently without patents, reflect her potential to influence the industry significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…